179 related articles for article (PubMed ID: 32106039)
1. Synthesis, biological evaluation and molecular docking studies of new amides of 4-chlorothiocolchicine as anticancer agents.
Klejborowska G; Urbaniak A; Maj E; Preto J; Moshari M; Wietrzyk J; Tuszynski JA; Chambers TC; Huczyński A
Bioorg Chem; 2020 Apr; 97():103664. PubMed ID: 32106039
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, biological evaluation and molecular docking studies of new amides of 4-bromothiocolchicine as anticancer agents.
Klejborowska G; Urbaniak A; Preto J; Maj E; Moshari M; Wietrzyk J; Tuszynski JA; Chambers TC; Huczyński A
Bioorg Med Chem; 2019 Dec; 27(23):115144. PubMed ID: 31653441
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, antiproliferative activity, and molecular docking studies of 4-chlorothiocolchicine analogues.
Klejborowska G; Moshari M; Maj E; Majcher U; Preto J; Wietrzyk J; Tuszynski JA; Huczyński A
Chem Biol Drug Des; 2020 Jan; 95(1):182-191. PubMed ID: 31483093
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, antiproliferative activity and molecular docking of thiocolchicine urethanes.
Majcher U; Urbaniak A; Maj E; Moshari M; Delgado M; Wietrzyk J; Bartl F; Chambers TC; Tuszynski JA; Huczyński A
Bioorg Chem; 2018 Dec; 81():553-566. PubMed ID: 30248507
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, Antiproliferative Activity and Molecular Docking Studies of Novel Doubly Modified Colchicine Amides and Sulfonamides as Anticancer Agents.
Krzywik J; Mozga W; Aminpour M; Janczak J; Maj E; Wietrzyk J; Tuszyński JA; Huczyński A
Molecules; 2020 Apr; 25(8):. PubMed ID: 32295119
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, anticancer activity and molecular docking studies of N-deacetylthiocolchicine and 4-iodo-N-deacetylthiocolchicine derivatives.
Klejborowska G; Urbaniak A; Maj E; Wietrzyk J; Moshari M; Preto J; Tuszynski JA; Chambers TC; Huczyński A
Bioorg Med Chem; 2021 Feb; 32():116014. PubMed ID: 33465696
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, biological evaluation, and molecular docking studies of cinnamic acyl 1,3,4-thiadiazole amide derivatives as novel antitubulin agents.
Yang XH; Wen Q; Zhao TT; Sun J; Li X; Xing M; Lu X; Zhu HL
Bioorg Med Chem; 2012 Feb; 20(3):1181-7. PubMed ID: 22261027
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and evaluation of novel bis-substituted aromatic amide dithiocarbamate derivatives as colchicine site tubulin polymerization inhibitors with potent anticancer activities.
Sun YX; Song J; Kong LJ; Sha BB; Tian XY; Liu XJ; Hu T; Chen P; Zhang SY
Eur J Med Chem; 2022 Feb; 229():114069. PubMed ID: 34971875
[TBL] [Abstract][Full Text] [Related]
9. An insight into the anticancer potential of carbamates and thiocarbamates of 10-demethoxy-10-methylaminocolchicine.
Krzywik J; Aminpour M; Janczak J; Maj E; Moshari M; Mozga W; Wietrzyk J; Tuszyński JA; Huczyński A
Eur J Med Chem; 2021 Apr; 215():113282. PubMed ID: 33611191
[TBL] [Abstract][Full Text] [Related]
10. New Series of Double-Modified Colchicine Derivatives: Synthesis, Cytotoxic Effect and Molecular Docking.
Krzywik J; Aminpour M; Maj E; Mozga W; Wietrzyk J; Tuszyński JA; Huczyński A
Molecules; 2020 Aug; 25(15):. PubMed ID: 32748887
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and biological evaluation of colchicine glycoconjugates as tubulin polymerization inhibitors.
Wang Z; Liu R; Zhang X; Chang X; Gao M; Zhang S; Guan Q; Sun J; Zuo D; Zhang W
Bioorg Med Chem; 2022 Mar; 58():116671. PubMed ID: 35193066
[TBL] [Abstract][Full Text] [Related]
12. The discovery of novel indazole derivatives as tubulin colchicine site binding agents that displayed potent antitumor activity both in vitro and in vivo.
Cui YJ; Ma CC; Zhang CM; Tang LQ; Liu ZP
Eur J Med Chem; 2020 Feb; 187():111968. PubMed ID: 31865012
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antiproliferative screening of novel doubly modified colchicines containing urea, thiourea and guanidine moieties.
Krzywik J; Maj E; Nasulewicz-Goldeman A; Mozga W; Wietrzyk J; Huczyński A
Bioorg Med Chem Lett; 2021 Sep; 47():128197. PubMed ID: 34116158
[TBL] [Abstract][Full Text] [Related]
14. Design, Synthesis, and Biological Evaluation of 1-Methyl-1,4-dihydroindeno[1,2-c]pyrazole Analogues as Potential Anticancer Agents Targeting Tubulin Colchicine Binding Site.
Liu YN; Wang JJ; Ji YT; Zhao GD; Tang LQ; Zhang CM; Guo XL; Liu ZP
J Med Chem; 2016 Jun; 59(11):5341-55. PubMed ID: 27172319
[TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of novel 5-(4-chlorophenyl)furan derivatives with inhibitory activity on tubulin polymerization.
Moussa SA; A Osman EE; Eid NM; Abou-Seri SM; El Moghazy SM
Future Med Chem; 2018 Aug; 10(16):1907-1924. PubMed ID: 29966433
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxic substituted indolizines as new colchicine site tubulin polymerisation inhibitors.
Sardaru MC; Craciun AM; Al Matarneh CM; Sandu IA; Amarandi RM; Popovici L; Ciobanu CI; Peptanariu D; Pinteala M; Mangalagiu II; Danac R
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1581-1595. PubMed ID: 32752898
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, structure-activity relationships and biological evaluation of 7-phenyl-pyrroloquinolinone 3-amide derivatives as potent antimitotic agents.
Carta D; Bortolozzi R; Sturlese M; Salmaso V; Hamel E; Basso G; Calderan L; Quintieri L; Moro S; Viola G; Ferlin MG
Eur J Med Chem; 2017 Feb; 127():643-660. PubMed ID: 27823884
[TBL] [Abstract][Full Text] [Related]
18. Design, concise synthesis and evaluation of novel amide-based combretastatin A-4 analogues as potent tubulin inhibitors.
Ma Y; Wang T; Cheng L; Ma X; Li R; Zhang M; Chen J; Zhao P
Bioorg Med Chem Lett; 2024 Aug; 108():129816. PubMed ID: 38806101
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, biological evaluation and molecular modeling of 1,3,4-thiadiazol-2-amide derivatives as novel antitubulin agents.
Li YJ; Qin YJ; Makawana JA; Wang YT; Zhang YQ; Zhang YL; Yang MR; Jiang AQ; Zhu HL
Bioorg Med Chem; 2014 Aug; 22(15):4312-22. PubMed ID: 24909678
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of novel benzo[c]acridine-diones as potential anticancer agents and tubulin polymerization inhibitors.
Behbahani FS; Tabeshpour J; Mirzaei S; Golmakaniyoon S; Tayarani-Najaran Z; Ghasemi A; Ghodsi R
Arch Pharm (Weinheim); 2019 Jun; 352(6):e1800307. PubMed ID: 31012156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
